NEJM published a study about the Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker:
“Treatment of prehypertension with candesartan …. reduced the risk of incident hypertension during the study period. Thus, treatment of prehypertension appears to be feasible.”
California Medicine Man is not so sure if this is a good idea.
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
